Description

Simple

Clinical

Overview

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Felbinac
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(R)-warfarin
The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with (R)-warfarin.
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with (S)-Warfarin.
1-benzylimidazole
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Felbinac.
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Felbinac.
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of hypertension can be increased when Felbinac is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Felbinac.
4-hydroxycoumarin
The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with 4-hydroxycoumarin.
4-Methoxyamphetamine
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Felbinac.
5-methoxy-N,N-dimethyltryptamine
The risk or severity of hypertension can be increased when Felbinac is combined with 5-methoxy-N,N-dimethyltryptamine.
Abacavir
Felbinac may decrease the excretion rate of Abacavir which could result in a higher serum level.
Abciximab
The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Abciximab.
Abediterol
The risk or severity of hypertension can be increased when Felbinac is combined with Abediterol.
Acarbose
Felbinac may decrease the excretion rate of Acarbose which could result in a higher serum level.
Acebutolol
Felbinac may decrease the antihypertensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Aceclofenac is combined with Felbinac.
Acemetacin
The risk or severity of adverse effects can be increased when Felbinac is combined with Acemetacin.
Acenocoumarol
The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Acenocoumarol.
Acepromazine
The risk or severity of hypertension can be increased when Acepromazine is combined with Felbinac.
Acetaminophen
The risk or severity of adverse effects can be increased when Acetaminophen is combined with Felbinac.
Acetohexamide
The protein binding of Acetohexamide can be decreased when combined with Felbinac.